References:
1. Bossone E, Eagle KA. Epidemiology and Management of Aortic Disease: Aortic Aneurysms and Acute Aortic Syndromes. Nature reviews Cardiology (2021) 18(5):331-48. Epub 2020/12/24. doi: 10.1038/s41569-020-00472-6.
2. Mutlu O, Salman HE, Al-Thani H, El-Menyar A, Qidwai UA, Yalcin HC. How Does Hemodynamics Affect Rupture Tissue Mechanics in Abdominal Aortic Aneurysm: Focus on Wall Shear Stress Derived Parameters, Time-Averaged Wall Shear Stress, Oscillatory Shear Index, Endothelial Cell Activation Potential, and Relative Residence Time. Computers in biology and medicine (2023) 154:106609. Epub 2023/02/02. doi: 10.1016/j.compbiomed.2023.106609.
3. Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, et al. 2014 Esc Guidelines on the Diagnosis and Treatment of Aortic Diseases: Document Covering Acute and Chronic Aortic Diseases of the Thoracic and Abdominal Aorta of the Adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (Esc). European heart journal (2014) 35(41):2873-926. Epub 2014/09/01. doi: 10.1093/eurheartj/ehu281.
4. Gao J, Cao H, Hu G, Wu Y, Xu Y, Cui H, et al. The Mechanism and Therapy of Aortic Aneurysms. Signal transduction and targeted therapy (2023) 8(1):55. Epub 2023/02/04. doi: 10.1038/s41392-023-01325-7.
5. Golledge J. Abdominal Aortic Aneurysm: Update on Pathogenesis and Medical Treatments. Nature reviews Cardiology (2019) 16(4):225-42. Epub 2018/11/18. doi: 10.1038/s41569-018-0114-9.
6. Scherlinger M, Richez C, Tsokos GC, Boilard E, Blanco P. The Role of Platelets in Immune-Mediated Inflammatory Diseases. Nature reviews Immunology (2023):1-16. Epub 2023/01/29. doi: 10.1038/s41577-023-00834-4.
7. McInnes IB, Gravallese EM. Immune-Mediated Inflammatory Disease Therapeutics: Past, Present and Future. Nature reviews Immunology(2021) 21(10):680-6. Epub 2021/09/15. doi: 10.1038/s41577-021-00603-1.
8. Conrad N, Verbeke G, Molenberghs G, Goetschalckx L, Callender T, Cambridge G, et al. Autoimmune Diseases and Cardiovascular Risk: A Population-Based Study on 19 Autoimmune Diseases and 12 Cardiovascular Diseases in 22 Million Individuals in the Uk. Lancet (London, England) (2022) 400(10354):733-43. Epub 2022/08/31. doi: 10.1016/s0140-6736(22)01349-6.
9. Agca R, Smulders Y, Nurmohamed M. Cardiovascular Disease Risk in Immune-Mediated Inflammatory Diseases: Recommendations for Clinical Practice. Heart (British Cardiac Society) (2022) 108(1):73-9. Epub 2021/03/07. doi: 10.1136/heartjnl-2019-316378.
10. Gisterå A, Hansson GK. The Immunology of Atherosclerosis.Nature reviews Nephrology (2017) 13(6):368-80. Epub 2017/04/11. doi: 10.1038/nrneph.2017.51.
11. Schmidt J, Sunesen K, Kornum JB, Duhaut P, Thomsen RW. Predictors for Pathologically Confirmed Aortitis after Resection of the Ascending Aorta: A 12-Year Danish Nationwide Population-Based Cross-Sectional Study. Arthritis research & therapy (2011) 13(3):R87. Epub 2011/06/17. doi: 10.1186/ar3360.
12. Shovman O, Tiosano S, Comaneshter D, Cohen AD, Amital H, Sherf M. Aortic Aneurysm Associated with Rheumatoid Arthritis: A Population-Based Cross-Sectional Study. Clinical rheumatology (2016) 35(11):2657-61. Epub 2016/08/10. doi: 10.1007/s10067-016-3372-0.
13. Pujades-Rodriguez M, Duyx B, Thomas SL, Stogiannis D, Rahman A, Smeeth L, et al. Rheumatoid Arthritis and Incidence of Twelve Initial Presentations of Cardiovascular Disease: A Population Record-Linkage Cohort Study in England. PloS one (2016) 11(3):e0151245. Epub 2016/03/16. doi: 10.1371/journal.pone.0151245.
14. Wang SH, Chang YS, Liu CJ, Lai CC, Chen TJ, Chen WS. Incidence and Risk Analysis of Aortic Aneurysm and Aortic Dissection among Patients with Systemic Lupus Erythematosus: A Nationwide Population-Based Study in Taiwan. Lupus (2014) 23(7):665-71. Epub 2014/02/21. doi: 10.1177/0961203314523868.
15. Guy A, Tiosano S, Comaneshter D, Tekes-Manova D, Shovman O, Cohen AD, et al. Aortic Aneurysm Association with Sle - a Case-Control Study.Lupus (2016) 25(9):959-63. Epub 2016/01/27. doi: 10.1177/0961203316628999.
16. Khalid U, Egeberg A, Ahlehoff O, Smedegaard L, Gislason GH, Hansen PR. Nationwide Study on the Risk of Abdominal Aortic Aneurysms in Patients with Psoriasis. Arteriosclerosis, thrombosis, and vascular biology (2016) 36(5):1043-8. Epub 2016/04/16. doi: 10.1161/atvbaha.116.307449.
17. Chiu HY, Lo PC, Huang WF, Tsai YW, Tsai TF. Increased Risk of Aortic Aneurysm (Aa) in Relation to the Severity of Psoriasis: A National Population-Based Matched-Cohort Study. Journal of the American Academy of Dermatology (2016) 75(4):747-54. Epub 2016/07/31. doi: 10.1016/j.jaad.2016.06.002.
18. Talathi S, Mannion M, Colvin E, Beck A, Dabal R, Maclin J, et al. Aortitis with an Aneurysm at Initial Presentation of Crohn Disease.Journal of pediatric gastroenterology and nutrition (2018) 67(1):e12-e3. Epub 2018/06/22. doi: 10.1097/mpg.0000000000001945.
19. Taddio A, Maschio M, Martelossi S, Barbi E, Ventura A. Crohn’s Disease and Takayasu’s Arteritis: An Uncommon Association. World journal of gastroenterology (2013) 19(35):5933-5. Epub 2013/10/15. doi: 10.3748/wjg.v19.i35.5933.
20. Kashima K, Kawasaki D, Yotsumoto G, Hatake S, Yamashita E, Nagayoshi S, et al. Rapid Progression of Aortic Regurgitation with Thoracic Aortic Aneurysm Due to Takayasu Arteritis Associated with Ulcerative Colitis.Internal medicine (Tokyo, Japan) (2010) 49(11):1007-11. Epub 2010/06/04. doi: 10.2169/internalmedicine.49.3122.
21. Haug ES, Skomsvoll JF, Jacobsen G, Halvorsen TB, Saether OD, Myhre HO. Inflammatory Aortic Aneurysm Is Associated with Increased Incidence of Autoimmune Disease. Journal of vascular surgery (2003) 38(3):492-7. Epub 2003/08/30. doi: 10.1016/s0741-5214(03)00340-9.
22. Tin A, Köttgen A. Mendelian Randomization Analysis as a Tool to Gain Insights into Causes of Diseases: A Primer. Journal of the American Society of Nephrology : JASN (2021) 32(10):2400-7. Epub 2021/06/18. doi: 10.1681/asn.2020121760.
23. Gupta V, Walia GK, Sachdeva MP. ’Mendelian Randomization’: An Approach for Exploring Causal Relations in Epidemiology. Public health (2017) 145:113-9. Epub 2017/04/01. doi: 10.1016/j.puhe.2016.12.033.
24. Boef AG, Dekkers OM, le Cessie S. Mendelian Randomization Studies: A Review of the Approaches Used and the Quality of Reporting.International journal of epidemiology (2015) 44(2):496-511. Epub 2015/05/09. doi: 10.1093/ije/dyv071.
25. Zheng J, Baird D, Borges MC, Bowden J, Hemani G, Haycock P, et al. Recent Developments in Mendelian Randomization Studies. Current epidemiology reports (2017) 4(4):330-45. Epub 2017/12/12. doi: 10.1007/s40471-017-0128-6.
26. Ha E, Bae SC, Kim K. Large-Scale Meta-Analysis across East Asian and European Populations Updated Genetic Architecture and Variant-Driven Biology of Rheumatoid Arthritis, Identifying 11 Novel Susceptibility Loci. Annals of the rheumatic diseases (2021) 80(5):558-65. Epub 2020/12/15. doi: 10.1136/annrheumdis-2020-219065.
27. Bentham J, Morris DL, Graham DSC, Pinder CL, Tombleson P, Behrens TW, et al. Genetic Association Analyses Implicate Aberrant Regulation of Innate and Adaptive Immunity Genes in the Pathogenesis of Systemic Lupus Erythematosus. Nature genetics (2015) 47(12):1457-64. Epub 2015/10/27. doi: 10.1038/ng.3434.
28. Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, et al. Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The Strobe-Mr Statement.Jama (2021) 326(16):1614-21. Epub 2021/10/27. doi: 10.1001/jama.2021.18236.
29. Jansen H, Samani NJ, Schunkert H. Mendelian Randomization Studies in Coronary Artery Disease. European heart journal (2014) 35(29):1917-24. Epub 2014/06/12. doi: 10.1093/eurheartj/ehu208.
30. Staley JR, Blackshaw J, Kamat MA, Ellis S, Surendran P, Sun BB, et al. Phenoscanner: A Database of Human Genotype-Phenotype Associations.Bioinformatics (Oxford, England) (2016) 32(20):3207-9. Epub 2016/06/19. doi: 10.1093/bioinformatics/btw373.
31. Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The Mr-Base Platform Supports Systematic Causal Inference across the Human Phenome. eLife (2018) 7. Epub 2018/05/31. doi: 10.7554/eLife.34408.
32. Papadimitriou N, Dimou N, Tsilidis KK, Banbury B, Martin RM, Lewis SJ, et al. Physical Activity and Risks of Breast and Colorectal Cancer: A Mendelian Randomisation Analysis. Nature communications (2020) 11(1):597. Epub 2020/02/01. doi: 10.1038/s41467-020-14389-8.
33. Lin Z, Deng Y, Pan W. Combining the Strengths of Inverse-Variance Weighting and Egger Regression in Mendelian Randomization Using a Mixture of Regressions Model. PLoS genetics (2021) 17(11):e1009922. Epub 2021/11/19. doi: 10.1371/journal.pgen.1009922.
34. Bowden J, Del Greco MF, Minelli C, Zhao Q, Lawlor DA, Sheehan NA, et al. Improving the Accuracy of Two-Sample Summary-Data Mendelian Randomization: Moving Beyond the Nome Assumption. International journal of epidemiology (2019) 48(3):728-42. Epub 2018/12/19. doi: 10.1093/ije/dyy258.
35. Verbanck M, Chen CY, Neale B, Do R. Detection of Widespread Horizontal Pleiotropy in Causal Relationships Inferred from Mendelian Randomization between Complex Traits and Diseases. Nature genetics (2018) 50(5):693-8. Epub 2018/04/25. doi: 10.1038/s41588-018-0099-7.
36. Bowden J, Davey Smith G, Burgess S. Mendelian Randomization with Invalid Instruments: Effect Estimation and Bias Detection through Egger Regression. International journal of epidemiology (2015) 44(2):512-25. Epub 2015/06/08. doi: 10.1093/ije/dyv080.
37. Werner N, Nickenig G, Sinning JM. Complex Pci Procedures: Challenges for the Interventional Cardiologist. Clinical research in cardiology : official journal of the German Cardiac Society (2018) 107(Suppl 2):64-73. Epub 2018/07/07. doi: 10.1007/s00392-018-1316-1.
38. Björck M, Wanhainen A. Pathophysiology of Aaa: Heredity Vs Environment. Progress in cardiovascular diseases (2013) 56(1):2-6. Epub 2013/09/03. doi: 10.1016/j.pcad.2013.05.003.
39. Wood AM, Kaptoge S, Butterworth AS, Willeit P, Warnakula S, Bolton T, et al. Risk Thresholds for Alcohol Consumption: Combined Analysis of Individual-Participant Data for 599 912 Current Drinkers in 83 Prospective Studies. Lancet (London, England) (2018) 391(10129):1513-23. Epub 2018/04/21. doi: 10.1016/s0140-6736(18)30134-x.
40. Ananthakrishnan AN, Kaplan GG, Bernstein CN, Burke KE, Lochhead PJ, Sasson AN, et al. Lifestyle, Behaviour, and Environmental Modification for the Management of Patients with Inflammatory Bowel Diseases: An International Organization for Study of Inflammatory Bowel Diseases Consensus. The lancet Gastroenterology & hepatology (2022) 7(7):666-78. Epub 2022/04/30. doi: 10.1016/s2468-1253(22)00021-8.
41. Pujades-Rodriguez M, Morgan AW, Cubbon RM, Wu J. Dose-Dependent Oral Glucocorticoid Cardiovascular Risks in People with Immune-Mediated Inflammatory Diseases: A Population-Based Cohort Study. PLoS medicine (2020) 17(12):e1003432. Epub 2020/12/04. doi: 10.1371/journal.pmed.1003432.
42. Rasmussen TE, Hallett JW, Jr., Metzger RL, Richardson DM, Harmsen WS, Goronzy JJ, et al. Genetic Risk Factors in Inflammatory Abdominal Aortic Aneurysms: Polymorphic Residue 70 in the Hla-Dr B1 Gene as a Key Genetic Element. Journal of vascular surgery (1997) 25(2):356-64. Epub 1997/02/01. doi: 10.1016/s0741-5214(97)70358-6.
43. Sakata N, Tashiro T, Uesugi N, Kawara T, Furuya K, Hirata Y, et al. Igg4-Positive Plasma Cells in Inflammatory Abdominal Aortic Aneurysm: The Possibility of an Aortic Manifestation of Igg4-Related Sclerosing Disease. The American journal of surgical pathology (2008) 32(4):553-9. Epub 2008/02/28. doi: 10.1097/PAS.0b013e31815a04db.
44. Ollier B. Shock Revelations About Hla-Dr4 – a Shortcut to Rheumatoid Arthritis? Nature medicine (1996) 2(3):279-80. Epub 1996/03/01. doi: 10.1038/nm0396-279.
45. Ali AA, Khalid KE, Mohammed SE, Akhtar MS, Saeed OK. Association of Human Leukocyte Antigen (Hla) Class Ii (Drb1 and Dqb1) Alleles and Haplotypes with Rheumatoid Arthritis in Sudanese Patients.Frontiers in immunology (2023) 14:1178546. Epub 2023/07/10. doi: 10.3389/fimmu.2023.1178546.
46. Atouf O, Benbouazza K, Brick C, Bzami F, Bennani N, Amine B, et al. Hla Polymorphism and Early Rheumatoid Arthritis in the Moroccan Population. Joint bone spine (2008) 75(5):554-8. Epub 2008/09/20. doi: 10.1016/j.jbspin.2008.01.027.
47. Fries JF, Wolfe F, Apple R, Erlich H, Bugawan T, Holmes T, et al. Hla-Drb1 Genotype Associations in 793 White Patients from a Rheumatoid Arthritis Inception Cohort: Frequency, Severity, and Treatment Bias.Arthritis and rheumatism (2002) 46(9):2320-9. Epub 2002/10/02. doi: 10.1002/art.10485.
48. Yang M, Kuang X, Li J, Pan Y, Tan M, Lu B, et al. Meta-Analysis of the Association of Hla-Drb1 with Rheumatoid Arthritis in Chinese Populations. BMC musculoskeletal disorders (2013) 14:307. Epub 2013/10/29. doi: 10.1186/1471-2474-14-307.
49. Benham H, Nel HJ, Law SC, Mehdi AM, Street S, Ramnoruth N, et al. Citrullinated Peptide Dendritic Cell Immunotherapy in Hla Risk Genotype-Positive Rheumatoid Arthritis Patients. Science translational medicine (2015) 7(290):290ra87. Epub 2015/06/05. doi: 10.1126/scitranslmed.aaa9301.